<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Curr Pharmacol Rep</span><span class="iso-abbrev" title="iso-abbrev">Curr Pharmacol Rep</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Current Pharmacology Reports</span></div><span class="issn-epub" tagx="issn" title="issn-epub">2198-641X</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Springer International Publishing</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Cham</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7921287">7921287</a></span><span class="publisher-id" title="publisher-id">254</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1007/s40495-021-00254-9">10.1007/s40495-021-00254-9</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Natural Products: From Chemistry to Pharmacology (C Ho, Section Editor)</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Determination of Potential Drug Candidate Molecules of the <i>Hypericum perforatum</i> for COVID-19 Treatment</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">YalÃ§Ä±n</span><span class="given-names" tagx="given-names" title="given-names">Serap</span></span><span class="address" title="address"><span class="email" tagx="email" title="email">syalcin@ahievran.edu.tr</span><span class="email" tagx="email" title="email">serapyalcin1982@gmail.com</span></span><a href="#Aff1">1</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">YalÃ§Ä±nkaya</span><span class="given-names" tagx="given-names" title="given-names">Seda</span></span><a href="#Aff2">2</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ercan</span><span class="given-names" tagx="given-names" title="given-names">Fahriye</span></span><a href="#Aff3">3</a></span><span class="citation_author_institution" id="Aff1">[1], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.411224.0</span><span class="institution-id" title="institution-id">0000 0004 0399 5752</span><span class="institution" title="institution">Department of Molecular Biology and Genetics, Faculty of Art and Sciences, </span><span class="institution" title="institution">KÄ±rsehir Ahi Evran University, </span></div></span><span class="citation_author_institution" id="Aff2">[2], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.45978.37</span><span class="institution-id" title="institution-id">0000 0004 0527 3171</span><span class="institution" title="institution">Department of Food Engineering, Faculty of Engineering, </span><span class="institution" title="institution">SÃ¼leyman Demirel University, </span></div></span><span class="citation_author_institution" id="Aff3">[3], <div class="institution-wrap" title="institution-wrap"><span class="institution-id" title="institution-id">grid.411224.0</span><span class="institution-id" title="institution-id">0000 0004 0399 5752</span><span class="institution" title="institution">Department of Plant Protection, Faculty of Agriculture, </span><span class="institution" title="institution">KÄ±rsehir Ahi Evran University, </span></div></span></div><span class="pub-date-epub" title="pub-date-epub">epub: <span>2021-3-3</span></span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">7</span><span class="history" title="history"><span class="accepted" title="accepted">accepted: 2021-2-7</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , </span><span class="license" title="license"><span class="license-p" title="license-p">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p id="Par1">The novel human coronavirus was firstly emerged in December 2019 in Wuhan, China, and has spread rapidly around the world. There is no known specific effective treatment of COVID-19. The most commonly used agents against this disease both in Turkey and around the world include chloroquine, hydroxychloroquine, lopinavir/ritonavir, favipiravir, and remdesivir. In the study, we investigated the drug potential of molecules that the components of an important medicinal plant <i>Hypericum perforatum</i> by using molecular docking and drug possibility properties of these molecules. The molecular docking results showed that the most stable complex was obtained with COVID-19 main protease and hypericin/isohypericin ligands with âˆ’ 11 kcal/mol binding energy. Furthermore, ADMET, drug-likeness features of compounds of <i>H. perforatum</i> were investigated using the rules of Lipinski, Veber, and Ghose. According to the results obtained, it has been shown that <i>H. perforatum</i> has the potential to be an effective drug in the COVID-19 pandemic. In the next stage, it is necessary to carry out the clinically necessary reliability studies of these components. It is thought that it can be used for the treatment of COVID-19 if our molecular docking results are found to be in high correlation with clinical studies.</p> <div class="supplementaryinformation" title="sec"> <div class="title" tagx="title" title="title">
Supplementary Information</div> <p>The online version contains supplementary material available at 10.1007/s40495-021-00254-9.</p> </div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
COVID-19</div> <div class="kwd" title="kwd"><i>Hypericum perforatum</i></div> <div class="kwd" title="kwd">
Molecular docking</div> <div class="kwd" title="kwd">
ADMET</div> <div class="kwd" title="kwd">
Drug-likeness drug</div> </div> </div> </div> <div class="body" title="body"> <div class="introduction" title="sec"> <div class="title" tagx="title" title="title">
Introduction</div> <p id="Par2"><i>Hypericum perforatum</i> is commonly known as St. Johnâ€™s wort around the world and in Turkey is known as yellow cantaron and blood grass. This species is highly important and remarkable because of its pharmacological effects like antidepressant, antiviral, and antibacterial properties. These features made it the most studied species of <i>Hypericum</i> [<a href="#CR1">1</a>].</p> <p id="Par3">Several studies of <i>H. perforatum</i> introduced that the chemical components of plant (naftodiantrone compounds (hypericin, psodohypericin), fluoroglusinols (hyperforin), flavonoids (hyperositis, quercetin), biflavones (biapigenin, amentoflavones) phenolic acids, (ferulic acid, caffeic acid), proanthocyanidins, and essential oils) have provided its pharmacological effects [<a href="#CR2">2</a>]. There are also studies showing that it has potent cytotoxic and proapoptotic effects against tumor cell lines and inhibits tumor-induced angiogenesis [<a href="#CR3">3</a>, <a href="#CR4">4</a>].</p> <p id="Par4">These medicinal plant extracts include complex phytochemicals, and the complete molecular characteristics of these pharmacologically important chemicals are still unknown. However, napthodianthrones are a considerable compound of <i>H. perforatum</i> extracts, and hypericin is the best-characterized member of this class. Hypericin is one of the main components of <i>H. perforatum</i>. It can be extracted from the plant or chemically synthesized and has powerful cytotoxic and proapoptotic effects on cancer cells [<a href="#CR5">5</a>]. The molecular mechanism of this component is not known, but previous studies have reported the different cellular pathways related to survival, necrosis, or apoptosis of the cell [<a href="#CR6">6</a>]. Therewithal, further studies are needed to reveal the action of these compounds.</p> <p id="Par5">COVID-19 is a new strain of coronavirus that affects primarily aging humans with especially dyspnea. Alveolar-interstitial pneumonia develops in 20% of patients with acute respiratory distress syndrome. This virus spreads rapidly worldwide, and the World Health Organization (WHO) has announced it as a pandemic disease [<a href="#CR7">7</a>]. There is no specific treatment known so far. Thus, new approaches to drug design and discovery can be used as a promising tool for the discovery of some therapeutic drug candidates against COVID-19. In this sense, molecular docking has become a promising and useful tool for drug design and development and attracts researchersâ€™ attention. With this useful tool, we tried to reveal the binding potential of the target protein and the ligands with drug potential [<a href="#CR8">8</a>, <a href="#CR9">9</a>].</p> <p id="Par6">Many drugs, including chloroquine, remdesivir, and hydroxychloroquine, have been shown to be effective against COVID-19 [<a href="#CR10">10</a>, <a href="#CR11">11</a>]. Most of these drugs are HIV protease inhibitors. Chloroquine and hydroxychloroquine are thought to cause changes in glycolysis transferases in the vesicles of the endoplasmic reticulum or trans-Golgi complex at low pH [<a href="#CR12">12</a>]. In the study, we have performed a docking procedure with COVID-19 (PDB ID: 6LU7) and main components of <i>H. perforatum</i> as a ligand.</p> </div> <div class="materialsandmethods" title="sec"> <div class="title" tagx="title" title="title">
Materials and Methods</div> <p id="Par7">Molecular docking calculations were performed in Autodock Vina software [<a href="#CR13">13</a>]. The water molecules and cofactors were removed from the protein to clearly see the protein-ligand interaction. COVID-19 main protease [<a href="#CR14">14</a>] was used as a protein, and the structure of this protein was freely available from the RCSB Protein Data Bank as a 3D theoretical model (PDB ID: 6LU7) (<a href="https://www.rcsb.org/structure/6LU7">https://www.rcsb.org/structure/6LU7</a>). Ligands used in the study and their properties are given in Table <a href="#Tab1">1</a>. Ligands were obtained from PubChem (<a href="https://pubchem.ncbi.nlm.nih.gov/">https://pubchem.ncbi.nlm.nih.gov/</a>). Protein-ligand interactions were screened by Molegro Molecular Viewer 2.5 (Molegro Molecular viewer free software) (<a href="http://www.molegro.com">http://www.molegro.com</a>) [<a href="#CR15">15</a>]. <div class="table-wrap_UNKNOWN" id="Tab1"><span class="label" tagx="label" title="label">Table 1</span> </div></p><p>Ligands used in the study and their properties</p>  <div class="graphic" position="anchor" id="d32e315" /> <div class="graphic" position="anchor" id="d32e316" /> <div class="graphic" position="anchor" id="d32e317" /> <div class="graphic" position="anchor" id="d32e318" />  <p /> <p id="Par8">The binding potential of chloroquine and hydroxychloroquine has been reviewed as a control ligand. 2D structure of the ligands was converted to energy-minimized 3D structure. The binding energy results calculated by Vina are presented in Table <a href="#Tab2">2</a>. All protein and ligands were validated before performing the in silico computations [<a href="#CR16">16</a>]. Protein and ligand interactions can be observed in Figs. 1â€"19 (Supplementary file <a href="#MOESM1">1</a>). <div class="table-wrap_UNKNOWN" id="Tab2"><span class="label" tagx="label" title="label">Table 2</span> </div></p><p>Target protein and drug candidate molecules (ligands) molecular docking results</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th>Ligands</th> <th>Binding energy (kcal/mol)</th> <th>H bound and a.a. side</th> </tr> </thead> <tbody> <tr> <td>Chloroquine</td> <td>âˆ’ 5.6 kcal/mol</td> <td>1 (Trp 218)</td> </tr> <tr> <td>Hydroxychloroquine</td> <td>âˆ’ 7.0 kcal/mol</td> <td>0</td> </tr> <tr> <td>Hypericin</td> <td>âˆ’ 11 kcal/mol</td> <td>6 (Asp 197x2; Lys 137; Leu 287x3)</td> </tr> <tr> <td>Protopseudohypericin</td> <td>âˆ’ 9.9 kcal/mol</td> <td>5 (Tyr 239x2; Leu 271, Leu 272; Thr 199)</td> </tr> <tr> <td>Hyperocide</td> <td>âˆ’ 9.5 kcal/mol</td> <td>5 (Asn274; Glu 270; Arg 279; Asn 277x2)</td> </tr> <tr> <td>Cryptochlorogenic acid</td> <td>âˆ’ 8.1 kcal/mol</td> <td>6 (Gly 183; Phe 181; Arg 188; Glu 55; Arg 40x2)</td> </tr> <tr> <td>Isohypericin</td> <td>âˆ’ 11.0 kcal/mol</td> <td>4 (Asp 197x2; Lys 137; Tyr 239)</td> </tr> <tr> <td>Mangiferin</td> <td>âˆ’ 9.7 kcal/mol</td> <td>6 (Thr 199; Asp 289; Leu 287; Tyr 239x2; Leu 271)</td> </tr> <tr> <td>Neochlorogenic acid</td> <td>âˆ’ 8.6 kcal/mol</td> <td>2 (Thr 292; Thr 111)</td> </tr> <tr> <td>Catechin</td> <td>âˆ’ 7.4 kcal/mol</td> <td>4 (Leu 287; Thr 199; Asp 197; Tyr 237)</td> </tr> <tr> <td>Protocatehuic acid</td> <td>âˆ’ 5.9 kcal/mol</td> <td>4 (Asn 277x2; Arg 279; Asn 221)</td> </tr> <tr> <td>2-Methyldecane</td> <td>âˆ’ 5.0 kcal/mol</td> <td>0</td> </tr> <tr> <td>Pseudohypericin</td> <td>âˆ’ 10.7 kcal/mol</td> <td>5(Thr 199, Tyr 237, Leu 272, Leu 287x2)</td> </tr> <tr> <td>Protohypericin</td> <td>âˆ’ 9.7 kcal/mol</td> <td>5 (Asn 238; Thr 199; Tyr 239x2; Leu 271; Leu 272)</td> </tr> <tr> <td>Adhyperforin</td> <td>âˆ’ 8.8 kcal/mol</td> <td>1 (Leu 287)</td> </tr> <tr> <td>Hiperforine</td> <td>âˆ’ 7.9 kcal/mol</td> <td>2 (Arg 279; Asn 274)</td> </tr> <tr> <td>Miquelianin</td> <td>âˆ’ 9.8 kcal/mol</td> <td>3 (Tyr 239; Leu 287; Thr 199)</td> </tr> <tr> <td>Biapigenin</td> <td>âˆ’ 9.8 kcal/mol</td> <td>6 (Leu 271; Leu 287x2; Tyr 239; Thr 199; Asn 238)</td> </tr> <tr> <td>Guaijaverin</td> <td>âˆ’ 9.3 kcal/mol</td> <td>5 (Asn 274; Glu 270; Arg 279; Asn 277x2)</td> </tr> <tr> <td>Epicatechin</td> <td>âˆ’ 7.9 kcal/mol</td> <td>5 (Tyr 237; Thr 199; Asp 289; Lys 137;Tyr 239)</td> </tr> <tr> <td>Norathyriol</td> <td>âˆ’ 7.1 kcal/mol</td> <td>3 (Arg 105; Gln 110; Thr 111)</td> </tr> <tr> <td>Beta-Ocimene</td> <td>âˆ’ 5.2 kcal/mol</td> <td>0</td> </tr> <tr> <td>2-Methyloctane</td> <td>âˆ’ 4.3 kcal/mol</td> <td>0</td> </tr> </tbody> </table>  <p /> </div> <div class="druglikenessandadmetpredictionforthecomponents" title="sec"> <div class="title" tagx="title" title="title">
Drug Likeness and ADMET Prediction for the Components</div> <p id="Par9">Currently, computer-based ADMET analyses are gaining for drug discovery [<a href="#CR17">17</a>]. ADMET analyses are used to decide the pharmacological structure from the perspective of drug discovery (<a href="http://biosig.unimelb.edu.au/pkcsm/prediction">http://biosig.unimelb.edu.au/pkcsm/prediction</a>). Pharmacokinetics and drug-likeness prediction of drug candidate molecule(s) were performed by online tools SwissADME (<a href="http://www.sib.swiss">http://www.sib.swiss</a>) (<a href="http://www.swissadme.ch/index.php">http://www.swissadme.ch/index.php</a>) [<a href="#CR18">18</a>, <a href="#CR19">19</a>] and admetSAR (<a href="http://lmmd.ecust.edu.cn/admetsar2/">http://lmmd.ecust.edu.cn/admetsar2/</a>) [<a href="#CR20">20</a>]. In addition, these toxicological predictions have applied to Lipinski, Ghose, and Veber rules and bioavailability scores [<a href="#CR21">21</a>â€"<a href="#CR23">23</a>].</p> </div> <div class="resultsanddiscussion" title="sec"> <div class="title" tagx="title" title="title">
Results and Discussion</div> <p id="Par10">Molecular docking results obtained from this study indicated a strong interaction between COVID-19 main protease and potential drug candidates. The binding strength was defined by use of scoring function based on the Lamarckian generic algorithm. The binding free energy may include electrostatic, hydrogen bonding, and van der Waals interactions [<a href="#CR14">14</a>]. The least binding energy refers to the most stable binding between protein and the ligand. According to these results, the best stable binding score was obtained between tested protein and hypericin/isohypericin ligands with same score (âˆ’ 11 kcal/mol binding energy). All of the docked structures were visualized in Molegro Molecular viewer (free academic).</p> <p id="Par11">In this study, human intestinal absorption, aqueous solubility levels, BBB penetration levels, CYP inhibition (CYP2D6, CYP3A4, CYP1A2, CYP2C19, CYP2C6, CYP2D6), hepatotoxicity, AMES toxicity, max. tolerated, dose etc. of compounds of <i>H. perforatum</i> were analyzed by prediction models. ADMET (absorption, distribution, metabolism, excretion, toxicity) analysis shows that compounds predicted good human intestinal absorption and no hepatotoxicity (Supplementary file <a href="#MOESM2">2</a>).</p> <p id="Par12">Drug-likeness can be characterized as a complex balance of different structural properties that determines whether a compound is a drug. These features are mainly lipophilicity, hydrogen bonding properties, molecule size, pharmacophoric features, and many others [<a href="#CR24">24</a>]. In addition, drug-likeness results of compounds are shown in Table <a href="#Tab3">3</a>. <div class="table-wrap_UNKNOWN" id="Tab3"><span class="label" tagx="label" title="label">Table 3</span> </div></p><p>Drug-likeness results of compounds</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th rowspan="2">Ligand</th> <th colspan="3">Drug-likeness</th> <th rowspan="2">Bioavailability score</th> </tr> <tr> <th>Lipinski</th> <th>Ghose</th> <th>Veber</th> </tr> </thead> <tbody> <tr> <td>Hypericin</td> <td>No; 2 violations: MW &amp;gt; 500, NHorOH &amp;gt; 5</td> <td>No; 3 violations: MW &amp;gt; 480, WLOGP &amp;gt; 5.6, MR &amp;gt; 130</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Pseudohypericin</td> <td>No; 2 violations: MW &amp;gt; 500, NHorOH &amp;gt; 5</td> <td>No; 2 violations: MW &amp;gt; 480, MR &amp;gt; 130</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Protopseudohypericin</td> <td>No; 2 violations: MW &amp;gt; 500, NHorOH &amp;gt; 5</td> <td>No; 2 violations: MW &amp;gt; 480, MR &amp;gt; 130</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Protohypericin</td> <td>No; 2 violations: MW &amp;gt; 500, NHorOH &amp;gt; 5</td> <td>No; 2 violations: MW &amp;gt; 480, MR &amp;gt; 130</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Hyperocide</td> <td>No; 2 violations: NorO &amp;gt; 10, NHorOH &amp;gt; 5</td> <td>No; 1 violation: WLOGP &amp;lt; âˆ’ 0.4</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Adhyperforin</td> <td>No; 2 violations: MW &amp;gt; 500, MLOGP &amp;gt; 4.15</td> <td>No; 4 violations: MW &amp;gt; 480, WLOGP &amp;gt; 5.6, MR &amp;gt; 130, #atoms &amp;gt; 70</td> <td>No; 1 violation: rotors &amp;gt; 10</td> <td>0,56</td> </tr> <tr> <td>Cryptochlorogenic acid</td> <td>Yes; 1 violation: NHorOH &amp;gt; 5</td> <td>No; 1 violation: WLOGP &amp;lt; âˆ’ 0.4</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,11</td> </tr> <tr> <td>Hiperforine</td> <td>No; 2 violations: MW &amp;gt; 500, MLOGP &amp;gt; 4.15</td> <td>No; 4 violations: MW &amp;gt; 480, WLOGP &amp;gt; 5.6, MR &amp;gt; 130, #atoms &amp;gt; 70</td> <td>No; 1 violation: rotors &amp;gt; 10</td> <td>0,56</td> </tr> <tr> <td>Isohypericin</td> <td>No; 2 violations: MW &amp;gt; 500, NHorOH &amp;gt; 5</td> <td>No; 3 violations: MW &amp;gt; 480, WLOGP &amp;gt; 5.6, MR &amp;gt; 130</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Miquelianin</td> <td>No; 2 violations: NorO&amp;gt;10, NHorOH&amp;gt;5</td> <td>No; 1 violation: WLOGP &amp;lt; âˆ’ 0.4</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,11</td> </tr> <tr> <td>Biapigenin</td> <td>No; 2 violations: MW &amp;gt; 500, NHorOH &amp;gt; 5</td> <td>No; 2 violations: MW &amp;gt; 480, MR &amp;gt; 130</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Mangiferin</td> <td>No; 2 violations: NorO &amp;gt; 10, NHorOH &amp;gt; 5</td> <td>No; 1 violation: WLOGP &amp;lt; âˆ’ 0.4</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Guaijaverin</td> <td>No; 2 violations: NorO &amp;gt; 10, NHorOH &amp;gt; 5</td> <td>Yes</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,17</td> </tr> <tr> <td>Neochlorogenic acid</td> <td>Yes; 1 violation: NHorOH &amp;gt; 5</td> <td>No; 1 violation: WLOGP &amp;lt; âˆ’ 0.4</td> <td>No; 1 violation: TPSA &amp;gt; 140</td> <td>0,11</td> </tr> <tr> <td>Epicatechin</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>0,55</td> </tr> <tr> <td>Catechin</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>0,55</td> </tr> <tr> <td>Norathyriol</td> <td>Yes</td> <td>Yes</td> <td>Yes</td> <td>0,55</td> </tr> <tr> <td>Protocatehuic acid</td> <td>Yes</td> <td>No; 3 violations: MW&amp;lt;160, MR&amp;lt;40, #atoms &amp;lt; 20</td> <td>Yes</td> <td>0,56</td> </tr> <tr> <td>Beta-Ocimene</td> <td>Yes</td> <td>No; 1 violation: MW &amp;lt; 160</td> <td>Yes</td> <td>0,55</td> </tr> <tr> <td>2-Methyldecane</td> <td>Yes; 1 violation: MLOGP &amp;gt; 4.15</td> <td>No; 1 violation: MW &amp;lt; 160</td> <td>Yes</td> <td>0,55</td> </tr> <tr> <td>2-Methyloctane</td> <td>Yes; 1 violation: MLOGP &amp;gt; 4.15</td> <td>No; 1 violation: MW &amp;lt; 160</td> <td>Yes</td> <td>0,55</td> </tr> </tbody> </table>  <p /> <p id="Par13">According to Lipinskiâ€™s rule (Pfizerâ€™s rule, Lipinskiâ€™s rule of five, RO5), the active drug has no more than one violation of the following properties including molecular weight (MW) â‰¤ 500, LogP â‰¤ 5, hydrogen bond acceptors â‰¤ 10, and hydrogen bond donors â‰¤ 5 [<a href="#CR21">21</a>]. According to Veber rules, the active drug has total hydrogen bonds â‰¤ 12, rotatable bonds â‰¤ 10, and polar surface area (PSA) â‰¤ 140 tend to have oral bioavailability â‰¥ 20% [<a href="#CR22">22</a>]. According to Ghose rules, active drug has Log P(âˆ’ 0.4~5.6), MR (molar refractivity (40~150), MW (160~480), number of atoms (20~70), and PSA &amp;lt; 140 [<a href="#CR23">23</a>].</p> <p id="Par14">Based on the drug-likeness analysis, guaijaverin, epicatechin, catechin, norathyriol, protocatechuic acid, beta-ocimene, 2-methyldecane, and 2-methyloctane were found in accordance with the Lipinskiâ€™s, Veberâ€™s, or Ghoseâ€™s rule. However, Lipinskiâ€™s rule of five may not apply to natural compounds. The only half of all FDA-approved small-molecule drugs are both used and compatible with the â€œrule of fiveâ€� [<a href="#CR25">25</a>]. Therefore, it has the potential to be used as a medicine in other molecules.</p> </div> <div class="conclusion" title="sec"> <div class="title" tagx="title" title="title">
Conclusion</div> <p id="Par15"><i>Hypericum</i> sp., used for many years as a medicinal plant for different treatments, has recently become popular with research for its different properties. This medicinal plant has long been used due to the beneficial effects it has on human health [<a href="#CR26">26</a>â€"<a href="#CR29">29</a>]. In our research, the possibility of this useful plant being used against COVID-19, which our country and other countries in the world have been fighting for a long time, has been investigated. Based on the results, it was concluded that <i>H. perforatum</i> could be effective against COVID-19 and it is hypothesized that compounds may be screened to in vitro and in vivo experimental analyses to indicate its inhibitory potency.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Information</div> <div class="sec" title="sec"> <p> </p><div class="local-data" title="local-data"> <div class="media" title="media"><a href="40495_2021_254_MOESM1_ESM.docx">LINK</a><span class="label" tagx="label" title="label">ESM 1</span> <p>(DOCX 16762 kb)</p>  </div> </div> <div class="local-data" title="local-data"> <div class="media" title="media"><a href="40495_2021_254_MOESM2_ESM.docx">LINK</a><span class="label" tagx="label" title="label">ESM 2</span> <p>(DOCX 100 kb)</p>  </div> </div> <p /> </div> </div> </div> <div class="back" title="back"> <div class="fn-group" title="fn-group"> <div class="fn-type-" title=""> <p>This article is part of the Topical Collection on <i>Natural Products: From Chemistry to Pharmacology</i></p> </div> <div class="fn-type-" title=""> <p><b>Publisherâ€™s Note</b></p> <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p> </div> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CR1" /><span class="label" tagx="label" title="label">1.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Barnes</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Anderson</span><span class="given-names" tagx="given-names" title="given-names">LA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Phillipson</span><span class="given-names" tagx="given-names" title="given-names">JD</span></span></span><span class="mixed-article-title" title="mixed-article-title">St Johnâ€™s wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties</span><span class="source" tagx="source" title="source">J Pharm Pharmacol</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">53</span><span class="issue" tagx="issue" title="issue">5</span><span class="fpage" tagx="fpage" title="fpage">583</span><span class="lpage" tagx="lpage" title="lpage">600</span><span class="pub-id"><a href="https://dx.doi.org/10.1211/0022357011775910">10.1211/0022357011775910</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11370698">11370698</a></span></span></li> <li tag="ref"><a name="CR2" /><span class="label" tagx="label" title="label">2.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Hostettmann K, Wolfender JL. St. John's Wort and its Active Principles in Depression and Anxiety. <i>Phytochemistry</i>. 2005:5â€"20. 10.1007/3-7643-7338-5_2.</span></li> <li tag="ref"><a name="CR3" /><span class="label" tagx="label" title="label">3.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Momekov</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ferdinandov</span><span class="given-names" tagx="given-names" title="given-names">D</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zheleva-Dimitrova</span><span class="given-names" tagx="given-names" title="given-names">D</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nedialkov</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Girreser</span><span class="given-names" tagx="given-names" title="given-names">U</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kitanov</span><span class="given-names" tagx="given-names" title="given-names">G</span></span></span><span class="mixed-article-title" title="mixed-article-title">Cytotoxic effects of hyperatomarin, a prenylated phloroglucinol from Hypericum annulatum Moris subsp. annulatum, in a panel of malignant cell lines</span><span class="source" tagx="source" title="source">Phytomedicine.</span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">15</span><span class="issue" tagx="issue" title="issue">11</span><span class="fpage" tagx="fpage" title="fpage">1010</span><span class="lpage" tagx="lpage" title="lpage">1015</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.phymed.2008.04.008">10.1016/j.phymed.2008.04.008</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18539018">18539018</a></span></span></li> <li tag="ref"><a name="CR4" /><span class="label" tagx="label" title="label">4.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Schempp CM, Kirkin V, Simon-Haarhaus B, Kersten A, Kiss J, Termeer CC, et al. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. Johnâ€™s wort that acts by induction of apoptosis. Oncogene. 2002;21(8):1242â€"50. 10.1038/sj.onc.1205190.</span></li> <li tag="ref"><a name="CR5" /><span class="label" tagx="label" title="label">5.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ercan</span><span class="given-names" tagx="given-names" title="given-names">FS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Azarkan</span><span class="given-names" tagx="given-names" title="given-names">SY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ercan</span><span class="given-names" tagx="given-names" title="given-names">N</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Koc</span><span class="given-names" tagx="given-names" title="given-names">M</span></span></span><span class="mixed-article-title" title="mixed-article-title">Sequence variants of CYP345a1 and CYP6a14 gene regions in Tribolium castaneum (Coleoptera: Tenebrionidae) adults treated with the novel characterÄ±zed Bolanthus turcicus (Caryophyllaceae) extract</span><span class="source" tagx="source" title="source">Mol Biol Res Commun</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">9</span><span class="issue" tagx="issue" title="issue">3</span><span class="fpage" tagx="fpage" title="fpage">105</span><span class="lpage" tagx="lpage" title="lpage">110</span><span class="pub-id"><a href="https://dx.doi.org/10.22099/mbrc.2020.35861.1472">10.22099/mbrc.2020.35861.1472</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/33313329">33313329</a></span></span></li> <li tag="ref"><a name="CR6" /><span class="label" tagx="label" title="label">6.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Theodossiou</span><span class="given-names" tagx="given-names" title="given-names">TA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hothersall</span><span class="given-names" tagx="given-names" title="given-names">JS</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">De Witte</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pantos</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Agostinis</span><span class="given-names" tagx="given-names" title="given-names">P</span></span></span><span class="mixed-article-title" title="mixed-article-title">The multifaceted photocytotoxic profile of hypericin</span><span class="source" tagx="source" title="source">Mol Pharm</span><span class="year" tagx="year" title="year">2009</span><span class="volume" tagx="volume" title="volume">6</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">1775</span><span class="lpage" tagx="lpage" title="lpage">1789</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/mp900166q">10.1021/mp900166q</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19739671">19739671</a></span></span></li> <li tag="ref"><a name="CR7" /><span class="label" tagx="label" title="label">7.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horby</span><span class="given-names" tagx="given-names" title="given-names">PW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hayden</span><span class="given-names" tagx="given-names" title="given-names">FG</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">GF</span></span></span><span class="mixed-article-title" title="mixed-article-title">A novel coronavirus outbreak of global health concern</span><span class="source" tagx="source" title="source">Lancet.</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">395</span><span class="issue" tagx="issue" title="issue">10223</span><span class="fpage" tagx="fpage" title="fpage">470</span><span class="lpage" tagx="lpage" title="lpage">473</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/S0140-6736(20)30185-9">10.1016/S0140-6736(20)30185-9</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31986257">31986257</a></span></span></li> <li tag="ref"><a name="CR8" /><span class="label" tagx="label" title="label">8.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">McConkey BJ, Sobolev V, Edelman M. The performance of current methods in ligandâ€"protein docking. <i>Curr Sci</i>. 2002:845â€"56. 10.2307/24107087.</span></li> <li tag="ref"><a name="CR9" /><span class="label" tagx="label" title="label">9.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abdelli</span><span class="given-names" tagx="given-names" title="given-names">I</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hassani</span><span class="given-names" tagx="given-names" title="given-names">F</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bekkel Brikci</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghalem</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="mixed-article-title" title="mixed-article-title"><i>In silico</i> study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by <i>Ammoides verticillata</i> components harvested from Western Algeria</span><span class="source" tagx="source" title="source">J Biomol Struct Dyn</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">14</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">14</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/07391102.2020.1763199">10.1080/07391102.2020.1763199</a></span></span></li> <li tag="ref"><a name="CR10" /><span class="label" tagx="label" title="label">10.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yao</span><span class="given-names" tagx="given-names" title="given-names">X</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ye</span><span class="given-names" tagx="given-names" title="given-names">F</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cui</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Niu</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">X</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">L</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dong</span><span class="given-names" tagx="given-names" title="given-names">E</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Song</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhan</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tan</span><span class="given-names" tagx="given-names" title="given-names">W</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="mixed-article-title" title="mixed-article-title">In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)</span><span class="source" tagx="source" title="source">Clin Infect Dis</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">71</span><span class="issue" tagx="issue" title="issue">15</span><span class="fpage" tagx="fpage" title="fpage">732</span><span class="lpage" tagx="lpage" title="lpage">739</span><span class="pub-id"><a href="https://dx.doi.org/10.1093/cid/ciaa237">10.1093/cid/ciaa237</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32150618">32150618</a></span></span></li> <li tag="ref"><a name="CR11" /><span class="label" tagx="label" title="label">11.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lim</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeon</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shin</span><span class="given-names" tagx="given-names" title="given-names">HY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Seong</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">WJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Choe</span><span class="given-names" tagx="given-names" title="given-names">KW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kang</span><span class="given-names" tagx="given-names" title="given-names">YM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">B</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Park</span><span class="given-names" tagx="given-names" title="given-names">SJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR</span><span class="source" tagx="source" title="source">J Korean Med Sci</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">35</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">e79</span><span class="pub-id"><a href="https://dx.doi.org/10.3346/jkms.2020.35.e79">10.3346/jkms.2020.35.e79</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32056407">32056407</a></span></span></li> <li tag="ref"><a name="CR12" /><span class="label" tagx="label" title="label">12.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Devaux</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rolain</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Colson</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Raoult</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="mixed-article-title" title="mixed-article-title">New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?</span><span class="source" tagx="source" title="source">Int J Antimicrob Agents</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">55</span><span class="issue" tagx="issue" title="issue">5</span><span class="fpage" tagx="fpage" title="fpage">105938</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.ijantimicag.2020.105938">10.1016/j.ijantimicag.2020.105938</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32171740">32171740</a></span></span></li> <li tag="ref"><a name="CR13" /><span class="label" tagx="label" title="label">13.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Trott</span><span class="given-names" tagx="given-names" title="given-names">O</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Olson</span><span class="given-names" tagx="given-names" title="given-names">AJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading</span><span class="source" tagx="source" title="source">J Comput Chem</span><span class="year" tagx="year" title="year">2010</span><span class="volume" tagx="volume" title="volume">31</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">455</span><span class="lpage" tagx="lpage" title="lpage">461</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jcc.21334">10.1002/jcc.21334</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19499576">19499576</a></span></span></li> <li tag="ref"><a name="CR14" /><span class="label" tagx="label" title="label">14.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289â€"293. 10.1038/s41586-020-2223-y.</span></li> <li tag="ref"><a name="CR15" /><span class="label" tagx="label" title="label">15.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Thomsen</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Christensen</span><span class="given-names" tagx="given-names" title="given-names">MH</span></span></span><span class="mixed-article-title" title="mixed-article-title">MolDock: a new technique for high-accuracy molecular docking</span><span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">49</span><span class="issue" tagx="issue" title="issue">11</span><span class="fpage" tagx="fpage" title="fpage">3315</span><span class="lpage" tagx="lpage" title="lpage">3321</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm051197e">10.1021/jm051197e</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16722650">16722650</a></span></span></li> <li tag="ref"><a name="CR16" /><span class="label" tagx="label" title="label">16.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Yalcin S, Sas EB, Cankaya N, Ercan F, Kurt M. The physical studies and interaction with anti-apoptotic proteins of 2-(bis (cyanomethyl) amino)-2-oxoethyl methacrylate molecule. <i>arXiv preprint arXiv:1910.00900</i>. 2019, DOI: 10.5488/CMP.22.33301</span></li> <li tag="ref"><a name="CR17" /><span class="label" tagx="label" title="label">17.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Ntie-Kang F, Lifongo LL, Mbah JA, Owono Owono LC, Megnassan E, Mbaze LM, Judson PN, Sippl W, Efange SM. In silico drug metabolism and pharmacokinetic profiles of natural products from medicinal plants in the Congo basin. In Silico Pharmacol 2013;1:12. doi: 10.1186/2193-9616-1-12.</span></li> <li tag="ref"><a name="CR18" /><span class="label" tagx="label" title="label">18.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zoete</span><span class="given-names" tagx="given-names" title="given-names">V</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daina</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bovigny</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Michielin</span><span class="given-names" tagx="given-names" title="given-names">O</span></span></span><span class="mixed-article-title" title="mixed-article-title">SwissSimilarity: a web tool for low to ultra high throughput ligand-based virtual screening</span><span class="source" tagx="source" title="source">J Chem Inf Model</span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">56</span><span class="issue" tagx="issue" title="issue">8</span><span class="fpage" tagx="fpage" title="fpage">1399</span><span class="lpage" tagx="lpage" title="lpage">1404</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jcim.6b00174">10.1021/acs.jcim.6b00174</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27391578">27391578</a></span></span></li> <li tag="ref"><a name="CR19" /><span class="label" tagx="label" title="label">19.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daina</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Michielin</span><span class="given-names" tagx="given-names" title="given-names">O</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zoete</span><span class="given-names" tagx="given-names" title="given-names">V</span></span></span><span class="mixed-article-title" title="mixed-article-title">SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</span><span class="source" tagx="source" title="source">Sci Rep</span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">7</span><span class="fpage" tagx="fpage" title="fpage">42717</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/srep42717">10.1038/srep42717</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28256516">28256516</a></span></span></li> <li tag="ref"><a name="CR20" /><span class="label" tagx="label" title="label">20.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">F</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">W</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">PW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span></span><span class="mixed-article-title" title="mixed-article-title">admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties</span><span class="source" tagx="source" title="source">J Chem Inf Model</span><span class="year" tagx="year" title="year">2012</span><span class="volume" tagx="volume" title="volume">52</span><span class="issue" tagx="issue" title="issue">11</span><span class="fpage" tagx="fpage" title="fpage">3099</span><span class="lpage" tagx="lpage" title="lpage">3105</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/ci300367a">10.1021/ci300367a</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23092397">23092397</a></span></span></li> <li tag="ref"><a name="CR21" /><span class="label" tagx="label" title="label">21.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipinski</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lombardo</span><span class="given-names" tagx="given-names" title="given-names">F</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dominy</span><span class="given-names" tagx="given-names" title="given-names">BW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feeney</span><span class="given-names" tagx="given-names" title="given-names">PJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span><span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">46</span><span class="issue" tagx="issue" title="issue">1-3</span><span class="fpage" tagx="fpage" title="fpage">3</span><span class="lpage" tagx="lpage" title="lpage">26</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/s0169-409x(00)00129-0">10.1016/s0169-409x(00)00129-0</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11259830">11259830</a></span></span></li> <li tag="ref"><a name="CR22" /><span class="label" tagx="label" title="label">22.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Veber</span><span class="given-names" tagx="given-names" title="given-names">DF</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Johnson</span><span class="given-names" tagx="given-names" title="given-names">SR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheng</span><span class="given-names" tagx="given-names" title="given-names">HY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">BR</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ward</span><span class="given-names" tagx="given-names" title="given-names">KW</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kopple</span><span class="given-names" tagx="given-names" title="given-names">KD</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular properties that influence the oral bioavailability of drug candidates</span><span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2002</span><span class="volume" tagx="volume" title="volume">45</span><span class="issue" tagx="issue" title="issue">12</span><span class="fpage" tagx="fpage" title="fpage">2615</span><span class="lpage" tagx="lpage" title="lpage">2623</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm020017n">10.1021/jm020017n</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12036371">12036371</a></span></span></li> <li tag="ref"><a name="CR23" /><span class="label" tagx="label" title="label">23.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ghose</span><span class="given-names" tagx="given-names" title="given-names">AK</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Viswanadhan</span><span class="given-names" tagx="given-names" title="given-names">VN</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wendoloski</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span></span><span class="mixed-article-title" title="mixed-article-title">A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases</span><span class="source" tagx="source" title="source">J Comb Chem</span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">1</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">55</span><span class="lpage" tagx="lpage" title="lpage">68</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/cc9800071">10.1021/cc9800071</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10746014">10746014</a></span></span></li> <li tag="ref"><a name="CR24" /><span class="label" tagx="label" title="label">24.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation">Turner JV, Agatonovic-Kustrin S. In book: Comprehensive Medicinal Chemistry II. 2007; DOI: 10.1016/B0-08-045044-X/00147-4</span></li> <li tag="ref"><a name="CR25" /><span class="label" tagx="label" title="label">25.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">MQ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wilkinson</span><span class="given-names" tagx="given-names" title="given-names">B</span></span></span><span class="mixed-article-title" title="mixed-article-title">Drug discovery beyond the â€˜rule-of-fiveâ€™</span><span class="source" tagx="source" title="source">Curr Opin Biotechnol</span><span class="year" tagx="year" title="year">2007</span><span class="volume" tagx="volume" title="volume">18</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">478</span><span class="lpage" tagx="lpage" title="lpage">488</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.copbio.2007.10.005">10.1016/j.copbio.2007.10.005</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18035532">18035532</a></span></span></li> <li tag="ref"><a name="CR26" /><span class="label" tagx="label" title="label">26.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yalcin</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular Docking, Drug Likeness, and ADMET Analyses of Passiflora compounds as P-glycoprotein (P-gp) inhibitor for the treatment of cancer</span><span class="source" tagx="source" title="source">Curr Pharmacol Rep</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">6</span><span class="fpage" tagx="fpage" title="fpage">1</span><span class="lpage" tagx="lpage" title="lpage">12</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s40495-020-00241-6">10.1007/s40495-020-00241-6</a></span></span></li> <li tag="ref"><a name="CR27" /><span class="label" tagx="label" title="label">27.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">CY</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mu</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gibbons</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="mixed-article-title" title="mixed-article-title">The phytochemistry and pharmacology of Hypericum</span><span class="source" tagx="source" title="source">Prog Chem Org Nat Prod</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">112</span><span class="fpage" tagx="fpage" title="fpage">85</span><span class="lpage" tagx="lpage" title="lpage">182</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/978-3-030-52966-6_2">10.1007/978-3-030-52966-6_2</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/33306173">33306173</a></span></span></li> <li tag="ref"><a name="CR28" /><span class="label" tagx="label" title="label">28.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">R</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ji</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kennelly</span><span class="given-names" tagx="given-names" title="given-names">EJ</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Long</span><span class="given-names" tagx="given-names" title="given-names">C</span></span></span><span class="mixed-article-title" title="mixed-article-title">Ethnopharmacology of Hypericum species in China: a comprehensive review on ethnobotany, phytochemistry and pharmacology</span><span class="source" tagx="source" title="source">J Ethnopharmacol</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">254</span><span class="fpage" tagx="fpage" title="fpage">112686</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jep.2020.112686">10.1016/j.jep.2020.112686</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32101776">32101776</a></span></span></li> <li tag="ref"><a name="CR29" /><span class="label" tagx="label" title="label">29.</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Allegra</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tonacci</span><span class="given-names" tagx="given-names" title="given-names">A</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Spagnolo</span><span class="given-names" tagx="given-names" title="given-names">EV</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Musolino</span><span class="given-names" tagx="given-names" title="given-names">C</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gangemi</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="mixed-article-title" title="mixed-article-title">Antiproliferative effects of St. Johnâ€™s wort, its derivatives, and other Hypericum species in hematologic malignancies</span><span class="source" tagx="source" title="source">Int J Mol Sci</span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">22</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">146</span><span class="pub-id"><a href="https://dx.doi.org/10.3390/ijms22010146">10.3390/ijms22010146</a></span></span></li> </ul> </div> </div>  </body></html>